PharMerica Reports Third Quarter 2015 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Acquisitions, Specialty and Brand Inflation Drive Pharmerica's (PMC) 3Q Beat; Cowen Reiterates Outperform
November 6, 2015 1:45 PM ESTCowen reiterated an Outperform rating and $39.00 price target on PharMerica (NYSE: PMC) following the company's 3Q earnings report. PMC reported 3Q adj. EPS of $0.39, ahead of consensus of $0.36. Revenue of $498.8M was up 6% y/y and also beat consensus of $480.3M, driven by recent... More
Pharmerica (PMC) Tops Q3 EPS by 3c
November 6, 2015 9:17 AM ESTPharmerica (NYSE: PMC) reported Q3 EPS of $0.39, $0.03 better than the analyst estimate of $0.36. Revenue for the quarter came in at $498.8 million versus the consensus estimate of $480.35 million.
For earnings history and earnings-related data on Pharmerica (PMC) click here.
... More